Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Mouse Ephrin A1 ELISA Kit (AC3040)
Cat.#: ASET-1629
Specifications
Description Mouse Ephrin A1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse Ephrin A1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 23.43 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 400-6400 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2441 Camel Insulin ELISA Kit (AC3852) Quantitative inquiry ASET-1608 Mouse LRP5 ELISA Kit (AC3019) Quantitative inquiry ASET-1417 Mouse Adenosine Receptor A2a ELISA Kit (AC2828) Quantitative inquiry ASET-2196 Human VMAT2 ELISA Kit (AC3607) Quantitative inquiry ASET-1873 Mouse Sprn ELISA Kit (AC3284) Quantitative inquiry ASET-1612 Human Nyctalopin ELISA Kit (AC3023) Quantitative inquiry ASET-1277 Rat BACE2 ELISA Kit (AC2688) Quantitative inquiry ASET-1589 Mouse Ki67 ELISA Kit (AC3000) Quantitative inquiry ASET-1769 Rat GRK2 ELISA Kit (AC3180) Quantitative inquiry ASET-1122 Rat CX3CR1 ELISA Kit (AC2533) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket